📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study. (2016)

First Author: Armstrong MJ
Attributed to:  Overcoming immunological barriers to regenerative medicine funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s0140-6736(15)00803-x

PubMed Identifier: 26608256

Publication URI: http://europepmc.org/abstract/MED/26608256

Type: Journal Article/Review

Volume: 387

Parent Publication: Lancet (London, England)

Issue: 10019

ISSN: 0140-6736